Kenichi Kumagaya

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.